In severe cases of clinical scleritis, molecularly targeted therapies that suppress T cells not only proved ineffective, but also exacerbated scleritis, while inhibitors of TNF and IL-6, which are involved in macrophage function, and B-cell inhibition were effective and consistent with the pathology implied by the animal model. The gene discussed is IL6; the disease is scleritis.